Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel d Opioid Receptor-Selective Agonist ChemotypeSJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82024-06-010PRE
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid ReceptorJOURNAL OF MEDICINAL CHEMISTRYIF6.82023-02-242OA
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid ReceptorsPHARMACEUTICALSIF4.82022-07-156OAAI
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator CapabilitiesMOLECULESIF4.62021-11-299OAAI
Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose用于治疗阿片类药物过量的工程快速和长效纳洛酮递送系统PHARMACEUTICAL RESEARCHIF4.32021-06-104OAAI
Identification of a Novel dOR Selective Agonist Chemotype, Notably Devoid of a Basic NitrogenFASEB JOURNALIF4.22021-05-140PRE
Modulating β-arrestin 2 recruitment at the δ-and μ-opioid receptors using peptidomimetic ligandsRSC MEDICINAL CHEMISTRYIF3.62021-01-017OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向